According to a new report from Intel Market Research, the global Neuraxial Anesthesia Drug market was valued at USD 1.25 billion in 2025 and is projected to reach USD 1.76 billion by 2034, growing at a steady CAGR of 5.1% during the forecast period (2026-2034). This growth trajectory reflects the increasing preference for regional anesthesia...